RankingsPricing
  1. US-listed companies
  2. BioXcel Therapeutics, Inc.
  3. Raw

BioXcel Therapeutics, Inc.BTAI

Market cap
$11.39M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Product revenue, net----012
Cost of goods sold----012
Research and development15265853918430
Selling, general and administrative----698334
Restructuring costs-----42
Total operating expenses----16017370
Loss from operations-20-34-82-107-160-172-67
Interest expense------15
Interest income---0363
Other (income) expense, net-----0020
Net loss-19-33-82-107-166-179-60
Earnings Per Share, Basic----4.05-5.92-6.15-23.51
Earnings Per Share, Diluted----4.05-5.92-6.15-23.51